Literature DB >> 6551165

Modification of amino groups in porcine pancreatic elastase with polyethylene glycol in relation to binding ability towards anti-serum and to enzymic activity.

A Koide, S Kobayashi.   

Abstract

Porcine pancreatic elastase was modified by activated polyethylene glycol (2-0-methoxy-polyethyleneglycol-4, 6-dichloro-s-triazine) with molecular weight of 5000. The modification of elastase in which three amino groups out of the total four amino groups in the molecular gave rise to a complete loss of the binding ability towards anti-elastase serum from rabbit. The modified enzyme showed 35% of the original enzymic activity towards succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide and 17% towards casein. The heat-denatured collagen was also digested by the modified elastase, but the enzymic activity towards the elastin substrate was completely lost. The inhibition of the modified elastase activity by alpha 2-macroglobulin was found to be lesser than that of non-modified elastase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6551165     DOI: 10.1016/0006-291x(83)90357-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

2.  Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase.

Authors:  F M Veronese; R Largajolli; E Boccù; C A Benassi; O Schiavon
Journal:  Appl Biochem Biotechnol       Date:  1985-04       Impact factor: 2.926

3.  Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.

Authors:  Qian Zhong; Olivia M Merkel; Joshua J Reineke; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2016-05-13       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.